BIOLIFE SOLUTIONS INC 8-K

What Happened

• On June 3, 2026, BioLife Solutions, Inc. filed a Current Report on Form 8‑K (Regulation FD disclosure) furnishing an investor presentation as Exhibit 99.1.
• The company said the presentation may be used by management at the Jefferies Global Healthcare Conference, at other investor conferences, and in meetings with investors, analysts and the investment community.
• The presentation is available on BioLife’s investor website. The filing was signed by CFO Troy Wichterman.

Key Details

• Filing date: June 3, 2026.
• Exhibit: 99.1 — Investor Presentation (furnished and incorporated by reference).
• Usage: To be presented at the Jefferies Global Healthcare Conference and other investor outreach.
• Access: Presentation posted at https://investors.biolifesolutions.com/investor_presentation.

Why It Matters

• Furnishing an investor presentation via Form 8‑K under Regulation FD ensures the company shares the same information broadly with the market when management speaks to investors.
• Investors should review the presentation for any operational or strategic updates management intends to discuss at the conference; material new information would be publicly available through this filing and the company website.